(VIANEWS) – Shares of NYXOAH (BEL 20: NYXH.BR) rose by a staggering 32.69% in 21 sessions from €4.63 to €6.15 at 13:25 EST on Wednesday, after two consecutive sessions in a row of gains. BEL 20 is sliding 0.06% to €3,683.03, after two sequential sessions in a row of gains.
NYXOAH’s last close was €5.91, 68.89% under its 52-week high of €19.00.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-0.68.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.17%.
Yearly Top and Bottom Value
NYXOAH’s stock is valued at €6.15 at 13:25 EST, way under its 52-week high of €19.00 and way above its 52-week low of €4.45.
Volume
Today’s last reported volume for NYXOAH is 1197 which is 93.88% below its average volume of 12772.
Volatility
NYXOAH’s last week, last month’s, and last quarter’s current intraday variation average was 2.83%, 1.03%, and 2.15%.
NYXOAH’s highest amplitude of average volatility was 2.83% (last week), 2.90% (last month), and 2.15% (last quarter).
More news about NYXOAH (NYXH.BR).
